weight loss tirzepatide vs semaglutide works better for me than Semaglutide vs Tirzepatide: Complete Comparison – Tirzepatide vs Semaglutide: An in-depth

Purpose-built for physicians Most adults with overweight or obesity discontinue GLP-1 therapy within 2 years Key takeaways: Of adults prescribed a GLP-1 receptor agonist, 53.6% ended therapy at 1 year and 72.2% stopped therapy at 2 years

The researchers concluded that using semaglutide to supplement behavioral therapy may help more patients achieve more than the 5% or 10% weight loss typically seen solely through behavioral interventions at 6 to 12 months

Beyond PlexusDx's personalized prescription programs, PlexusDx provides quick-access supplements designed to support overall wellness and enhance your progress

Yes: Proceed to Question 3 No: Start metformin trial

7 Dual agonists such as tirzepatide (GLP-1/GIP) and mazdutide (GLP-1/glucagon), as well as triple agonists like retatrutide (GLP-1/GIP/glucagon), have demonstrated unprecedented weight loss and cardiometabolic benefits in adult clinical trials

Baseline characteristics of case and control subjects after matching Values are presented as meanstandard deviation or number (%)